Catalog Number Pack Size List Price* Quantity
HY-P99032-1MG 1 mg 695,00 Add
HY-P99032-5MG 5 mg 1'884,00 Add

* CHF, excl. 7.7% VAT and shipping costs

Product Description

35% discount on MedChem product orders above CHF 1'000 !
- 1st November - 31st December 2023
- Not cumulative with the "30% off Screening Libraries Promotion"

Monalizumab is a first-in-class immune checkpoint inhibitor targeting Natural Killer Group 2A (NKG2A). Monalizumab, a humanized anti-NKG2A blocking mAb, increases IFN-γ production, thereby promoting NK cell effector functions. Monalizumab can be used for the research of head and neck squamous cell carcinoma (HNSCC)[1][2].

Category Antibody
Supplier MedChem Express
Regulatory Status RUO
Research Field Cancer, Inflammation/Immunology, Cell Cycle/DNA Damage,Immunology/Inflammation
Format Solubility: H2O
Grade Clinical information: Phase 3
Purity 99.69%
CAS-Number 1228763-95-8
Storage Conditions Store at -80°C for 2 years
Disclaimer Shipped on dry ice - extra freight charge will occur
Product Line Biosimilar
Tech. Data Sheet View datasheet
Link To Supplier
Shipping Details Dry Ice
Material Safety Data Sheet Download PDF